tiprankstipranks
Trending News
More News >
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
US Market

Lexaria Bioscience (LEXX) Income Statement

Compare
239 Followers

Lexaria Bioscience Income Statement

Last quarter (Q1 2026), Lexaria Bioscience's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, Lexaria Bioscience's net income was $-1.60M. See Lexaria Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 705.92K$ 464.28K$ 226.21K$ 255.40K$ 722.74K
Gross Profit
$ 587.35K$ 383.30K$ 53.96K$ 46.71K$ 547.39K
Operating Expenses
$ 12.22M$ 6.08M$ 6.59M$ 6.55M$ 6.07M
Depreciation and Amortization
$ 115.85K$ 76.15K$ 145.40K$ 146.91K$ 147.60K
EBITDA
$ -11.80M$ -5.73M$ -6.57M$ -7.24M$ -4.02M
Operating Income
$ -11.63M$ -5.70M$ -6.53M$ -6.50M$ -5.52M
Other Income/Expenses
$ -278.06K$ -113.36K$ -178.50K$ -882.81K$ 1.36M
Pretax Income
$ -11.91M$ -5.81M$ -6.71M$ -7.38M$ -4.16M
Net Income
$ -11.90M$ -5.80M$ -6.66M$ -7.27M$ -4.03M
Per Share Metrics
Basic EPS
$ -0.66$ -0.47$ -1.01$ -1.24$ -0.92
Diluted EPS
$ -0.66$ -0.47$ -1.01$ -1.24$ -0.92
Weighted Average Shares Outstanding
18.00M 12.38M 6.61M 5.89M 4.39M
Weighted Average Shares Outstanding (Diluted)
18.00M 12.38M 6.61M 5.89M 4.39M
Currency in USD

Lexaria Bioscience Earnings and Revenue History